Roshni Dasgupta · Immature teratoma of the ovary with microscopic yolk sac tumor in children and adolescents: A multi-institutional study
Follow
Article1 min read·Published Jul 2026

Immature teratoma of the ovary with microscopic yolk sac tumor in children and adolescents: A multi-institutional study

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jul 2026 · 1 min read

In brief

In brief

Multi-institutional study of 143 pediatric patients shows that microscopic yolk sac tumor foci within ovarian immature teratomas correlate with higher-grade disease but do not significantly impact recurrence-free survival compared to pure immature teratomas. Findings suggest favorable outcomes despite more aggressive initial presentation.

Written by the GCMD Library team from the article.

Roshni Dasgupta

Objective: Immature teratoma (IT) of the ovary is an uncommon tumor with controversial management. The significance of microscopic yolk sac tumor (YST) within ovarian IT is unclear. We therefore aim to review the characteristics, management and outcomes of pediatric and adolescent patients with ovarian IT containing microscopic foci of YST and compare these patients to those without microscopic foci of YST, with a specific focus on recurrence-free survival (RFS). Methods: A multicenter review was performed by 29 institutions participating in the Pediatric Surgical Oncology Research Collaborative of females <18 years with ovarian IT diagnosed between 2010 and 2022. Patients with microscopic foci of YST (defined as ≤5% or documented by the institutional pathologist as a microscopic, single focus) were compared to those without. Results: We identified 143 females with ovarian IT, with 16 (11.1%) containing microscopic foci of YST. Patients with microfoci of YST were more likely to have higher-grade, higher-stage tumors, and higher alpha fetoprotein values at diagnosis than those without microscopic YST. Those with microscopic YST were more likely to receive chemotherapy (68.8%). There were 3 overall recurrences in the YST group (18.8%). There was no difference in RFS between those with and without YST; malignant recurrence was seen in 6.25% of those with YST vs. 7.1% of those of without. Conclusions: Children and adolescents with ovarian IT containing microscopic YST have favora

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →